VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 155 filers reported holding VENTYX BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 4.59 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 746,370 | $24,480,936 | 25.72% |
| venBio Partners LLC | 424,032 | $13,908,250 | 5.03% |
| TCG Crossover Management, LLC | 815,724 | $26,755,747 | 4.39% |
| ACUTA CAPITAL PARTNERS, LLC | 147,318 | $4,832,030 | 3.27% |
| Ikarian Capital, LLC | 374,100 | $12,270,480 | 1.95% |
| Integral Health Asset Management, LLC | 350,000 | $11,480,000 | 1.42% |
| Boxer Capital, LLC | 850,000 | $27,880 | 1.29% |
| Redmile Group, LLC | 940,493 | $30,848,170 | 1.18% |
| Affinity Asset Advisors, LLC | 100,696 | $3,302,829 | 1.15% |
| Logos Global Management LP | 250,000 | $8,200,000 | 1.12% |
| Vivo Capital, LLC | 422,075 | $13,844,060 | 0.96% |
| Avidity Partners Management LP | 692,500 | $22,714,000 | 0.79% |
| Tri Locum Partners LP | 57,800 | $1,895,840 | 0.70% |
| Birchview Capital, LP | 26,400 | $865,920 | 0.65% |
| Nantahala Capital Management | 192,671 | $6,319,609 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 617,000 | $20,237,600 | 0.43% |
| Artal Group S.A. | 408,519 | $13,399 | 0.42% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 963,196 | $31,592,829 | 0.40% |
| Diametric Capital, LP | 24,131 | $791,497 | 0.35% |
| GMT CAPITAL CORP | 280,600 | $9,203,680 | 0.35% |
This page lists VENTYX BIOSCIENCES INC's shareholders in Q2 2023. To view VENTYX BIOSCIENCES INC's shareholder history, click here.